- Previous Close
9.00 - Open
8.97 - Bid 8.80 x --
- Ask 8.81 x --
- Day's Range
8.79 - 9.05 - 52 Week Range
6.76 - 9.72 - Volume
15,650,962 - Avg. Volume
16,839,997 - Market Cap (intraday)
10.79B - Beta (5Y Monthly) 0.59
- PE Ratio (TTM)
18.72 - EPS (TTM)
0.47 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date May 19, 2023
- 1y Target Est
--
Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss, anti-viral, anti-TB, animal healthcare, and others. The company also exports its products to approximately 70 countries worldwide. The company was founded in 1956 and is headquartered in Taizhou, China.
www.hisunpharm.com8,062
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 600267.SS
View MorePerformance Overview: 600267.SS
Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600267.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600267.SS
View MoreValuation Measures
Market Cap
10.79B
Enterprise Value
13.40B
Trailing P/E
18.75
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.06
Price/Book (mrq)
1.26
Enterprise Value/Revenue
1.38
Enterprise Value/EBITDA
16.05
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.21%
Return on Assets (ttm)
0.99%
Return on Equity (ttm)
-0.52%
Revenue (ttm)
9.55B
Net Income Avi to Common (ttm)
-20.24M
Diluted EPS (ttm)
0.47
Balance Sheet and Cash Flow
Total Cash (mrq)
1.48B
Total Debt/Equity (mrq)
55.23%
Levered Free Cash Flow (ttm)
1.47B